Skip to content
healthcare.dev

TYENNE

NDC 65219-596, Tocilizumab-aazg, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
65219-596
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761449
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65219-596 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOCILIZUMAB162 mg/.9mL

Pharmacologic classes

Interleukin 6 Receptor Antagonists [MoA]; Interleukin-6 Receptor Antagonist [EPC]

Package NDCNDC-11Package
65219-596-01652190596011 SYRINGE, GLASS in 1 CARTON (65219-596-01) / .9 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/87ac5047-4f2b-4571-a8a8-32e08865f379
  • NADAC price for package 65219059601

    GET /v1/drugs/nadac/65219059601

Use it

Look up 65219-596 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65219-596 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65219-596. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.